blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3174554

EP3174554 - NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  31.05.2019
Database last updated on 14.09.2024
FormerExamination is in progress
Status updated on  29.06.2018
FormerRequest for examination was made
Status updated on  15.06.2017
FormerThe international publication has been made
Status updated on  06.01.2017
Most recent event   Tooltip31.05.2019Application deemed to be withdrawnpublished on 03.07.2019  [2019/27]
Applicant(s)For all designated states
Boehringer Ingelheim Vetmedica GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2017/23]
Inventor(s)01 / FRANCIS, Donny
Friedberger Landstrasse 118
60316 Frankfurt am Main / DE
02 / LAMPRECHT, Alf
Auf dem Eichholzer Acker 38
50389 Wesseling / DE
03 / FOLGER, Martin
Boehringer Ingelheim GmbH
Corporate Patents
Binger Straße 173
55216 Ingelheim Am Rhein / DE
04 / HOFFMANN, Ragna
Boehringer Ingelheim GmbH
Corporate Patents
Binger Straße 173
55216 Ingelheim Am Rhein / DE
05 / MARTIN-FONTECHA, Alfonso
Boehringer Ingelheim GmbH
Corporate Patents
Binger Straße 173
55216 Ingelheim Am Rhein / DE
 [2017/23]
Representative(s)Simon, Elke Anna Maria, et al
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2017/23]
Application number, filing date15750303.830.07.2015
[2017/23]
WO2015EP67594
Priority number, dateEP2014017953701.08.2014         Original published format: EP 14179537
[2017/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016016401
Date:04.02.2016
Language:EN
[2016/05]
Type: A1 Application with search report 
No.:EP3174554
Date:07.06.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 04.02.2016 takes the place of the publication of the European patent application.
[2017/23]
Search report(s)International search report - published on:EP04.02.2016
ClassificationIPC:A61K47/50
[2017/23]
CPC:
A61K47/6937 (EP,US); A61K9/1676 (US); A61K39/08 (CN,US);
A61K9/1647 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/23]
TitleGerman:NANOPARTIKEL, VERFAHREN ZUR HERSTELLUNG UND VERWENDUNGEN DAVON[2017/23]
English:NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF[2017/23]
French:NANOPARTICULES, PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS[2017/23]
Entry into regional phase01.03.2017National basic fee paid 
01.03.2017Designation fee(s) paid 
01.03.2017Examination fee paid 
Examination procedure05.01.2017Date on which the examining division has become responsible
01.03.2017Examination requested  [2017/23]
07.09.2017Amendment by applicant (claims and/or description)
29.06.2018Despatch of a communication from the examining division (Time limit: M06)
10.01.2019Application deemed to be withdrawn, date of legal effect  [2019/27]
15.02.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/27]
Fees paidRenewal fee
31.07.2017Renewal fee patent year 03
31.07.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2008051291  (ORDWAY RES INST [US], et al) [X] 1-6,13-18 * pages 60, 63, 65, 66, 69, and 168/169;; example 22 *;
 [Y]WO2008115641  (UNIV YALE [US], et al) [Y] 1-18 * example 2 *;
 [X]WO2008124632  (MASSACHUSETTS INST TECHNOLOGY [US], et al) [X] 1-6,13-18 * example 4 *;
 [XYI]US2012156135  (FAROKHZAD OMID C [US], et al) [X] 1-9,13-18 * paragraph [0214]; examples 1,2 * [Y] 12 [I] 10,11;
 [X]  - JUNG T ET AL, "Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20000701), vol. 67, no. 2-3, doi:10.1016/S0168-3659(00)00201-7, ISSN 0168-3659, pages 157 - 169, XP004199165 [X] 1-7 * page 166, column l, line 4 - line 6; figure 3 *

DOI:   http://dx.doi.org/10.1016/S0168-3659(00)00201-7
 [XY]  - TOBIAS JUNG ET AL, PHARMACEUTICAL RESEARCH, (20020101), vol. 19, no. 8, doi:10.1023/A:1019833822997, ISSN 0724-8741, pages 1105 - 1113, XP055215374 [X] 1-9,11,13-18 * page 1106, column l, paragraph 2; figure 1 * * page 1106, column r, paragraph l; figure 1 * [Y] 12

DOI:   http://dx.doi.org/10.1023/A:1019833822997
 [XY]  - DEMENTO S L ET AL, "Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy", VACCINE, ELSEVIER LTD, GB, vol. 27, no. 23, doi:10.1016/J.VACCINE.2009.03.034, ISSN 0264-410X, (20090518), pages 3013 - 3021, (20090403), XP026058717 [X] 1-11,13-18 * figure 5 * [Y] 12

DOI:   http://dx.doi.org/10.1016/j.vaccine.2009.03.034
 [XY]  - HU CHE-MING J ET AL, "Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20110705), vol. 108, no. 27, doi:10.1073/PNAS.1106634108, ISSN 0027-8424, pages 10980 - 10985, XP002738629 [X] 1-11,13-18 * figure 1 * [Y] 12

DOI:   http://dx.doi.org/10.1073/PNAS.1106634108
 [Y]  - O'HAGAN D T ET AL, "Microparticle-based technologies for vaccines", METHODS, ACADEMIC PRESS, vol. 40, no. 1, doi:10.1016/J.YMETH.2006.05.017, ISSN 1046-2023, (20060901), pages 10 - 19, (20060901), XP024908467 [Y] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.ymeth.2006.05.017
 [Y]  - MUTSUMI YOSHIDA ET AL, "Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, (20041001), vol. 71A, no. 1, doi:10.1002/jbm.a.30131, ISSN 0021-9304, pages 45 - 54, XP055215284 [Y] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1002/jbm.a.30131
 [Y]  - SINGH M ET AL, "Cationic microparticles are an effective delivery system for immunie stimulatory CpG DNA", PHARMACEUTICAL RESEARCH, SPRINGER NEW YORK LLC, US, (20011001), vol. 18, no. 10, doi:10.1023/A:1012269226066, ISSN 0724-8741, pages 1476 - 1479, XP002976979 [Y] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1023/A:1012269226066
 [Y]  - SINGH MANMOHAN ET AL, "Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, (20040201), vol. 93, no. 2, ISSN 0022-3549, pages 273 - 282, XP002632951 [Y] 1-18 * the whole document *
 [Y]  - KAZZAZ J ET AL, "Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20000701), vol. 67, no. 2-3, doi:10.1016/S0168-3659(00)00226-1, ISSN 0168-3659, pages 347 - 356, XP004199181 [Y] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0168-3659(00)00226-1
 [Y]  - MAURICIO A. ARIAS ET AL, "Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140", PLOS ONE, (20120101), vol. 7, no. 7, doi:10.1371/journal.pone.0041144, ISSN 1932-6203, page e41144, XP055047355 [Y] 12 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0041144
ExaminationWO2009128950
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.